Neutralizing TNFα restores glucocorticoid sensitivity in a mouse model of neutrophilic airway inflammation

Mucosal Immunology

Volumn 8, Issue 6, 2015, Pages 1212-1225

  Dejager, L ^a,b   Dendoncker, K ^a,b   Eggermont, M ^a,b   Souffriau, J ^a,b   Van Hauwermeiren, F ^a,b   Willart, M ^a,b   Van Wonterghem, E ^a,b   Naessens, T ^b   Ballegeer, M ^a,b   Vandevyver, S ^a,b   Hammad, H ^a,b   Lambrecht, B ^a,b,c   De Bosscher, K ^a,b   Grooten, J ^b   Libert, C ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ETANERCEPT; GLUCOCORTICOID; THYMIC STROMAL LYMPHOPOIETIN; TUMOR NECROSIS FACTOR ALPHA; ANTIASTHMATIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; FEMALE; KNOCKOUT MOUSE; MOUSE; NEUTROPHIL; NEUTROPHILIC AIRWAY INFLAMMATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; TH1 CELL; TH2 CELL; TRANSCRIPTION REGULATION; TREATMENT RESPONSE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; DRUG RESISTANCE; HYPERSENSITIVITY; IMMUNOASSAY; IMMUNOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; DISEASE MODELS, ANIMAL; DRUG RESISTANCE; ETANERCEPT; FEMALE; GLUCOCORTICOIDS; HYPERSENSITIVITY; IMMUNOASSAY; IMMUNOSUPPRESSIVE AGENTS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84945188133     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.12     Document Type: Article

References (59)

1. Vandevyver S., Dejager L., Tuckermann J., & Libert C. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation. Endocrinology 154, 993-1007 (2013
2. Surjit M., et al. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145, 224-241 (2011
3. Dockrell M., Partridge M.R., & Valovirta E. The limitations of severe asthma: the results of a European survey. Allergy 62, 134-141 (2007
4. Holgate S.T., & Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 368, 780-793 (2006
5. Chanez P., et al. Severe asthma in adults: what are the important questions?. J. Allergy Clin. Immunol. 119, 1337-1348 (2007
6. Barnes P.J. New therapies for asthma: is there any progress?. Trends Pharmacol. Sci. 31, 335-343 (2010
7. Anderson G.P. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet 372, 1107-1119 (2008
8. Wenzel S.E. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat. Med. 18, 716-725 (2012
9. Lambrecht B.N., & Hammad H. The airway epithelium in asthma. Nat. Med. 18, 684-692 (2012
10. Hallstrand T.S., Woodruff P.G., Holgate S.T., & Knight D.A. Function of the airway epithelium in asthma. J. Allergy 2012, 160586 (2012
11. Ordonez C.L., Shaughnessy T.E., Matthay M.A., & Fahy J.V. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma: clinical and biologic significance. Am. J. Respir. Crit. Care Med. 161, 1185-1190 (2000
12. Schuijs M.J., Willart M.A., Hammad H., & Lambrecht B.N. Cytokine targets in airway inflammation. Curr. Opin. Pharmacol. 13, 351-361 (2013
13. Lukacs N.W., Strieter R.M., Chensue S.W., Widmer M., & Kunkel S.L. Tnf-alpha mediates recruitment of neutrophils and eosinophils during airway inflammation. J. Immunol. 154, 5411-5417 (1995
14. Howarth P.H., et al. Tumour necrosis factor (TNF alpha) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 60, 1012-1018 (2005
15. Berry M.A., et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N. Engl. J. Med. 354, 697-708 (2006
16. Wenzel S.E., et al. A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma. Am. J Respir. Crit. Care Med. 179, 549-558 (2009
17. Holgate S.T., et al. Efficacy and safety of etanercept inmoderate-to-severe asthma: a randomised, controlled trial. Eur. Respirat. J. 37, 1352-1359 (2011
18. Bogaert P., et al. Inflammatory signatures for eosinophilic vs. neutrophilic allergic pulmonary inflammation reveal critical regulatory checkpoints. Am. J. Physiol. Lung Cell. Mol. Physiol 300, L679-L690 (2011
19. Busse W.W., Banks-Schlegel S., & Wenzel S.E. Pathophysiology of severe asthma. J. Allergy Clin. Immunol. 106, 1033-1042 (2000
20. Ming W.J., Bersani L., & Mantovani A. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J. Immunol. 138, 1469-1474 (1987
21. Van Hauwermeiren F., et al. Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium. J. Clin. Invest. 123, 2590-2603 (2013
22. Matthews J.G., Ito K., Barnes P.J., & Adcock I.M. Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J. Allergy Clin. Immunol. 113, 1100-1108 (2004
23. Zhou B.H., et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat. Immunol. 6, 1047-1053 (2005
24. Kabata H., et al. Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation. Nat. Commun. 4, 2675 (2013
25. Hansbro P.M., Kaiko G.E., & Foster P.S. Cytokine/anti-cytokine therapy -novel treatments for asthma?. Br. J. Pharmacol. 163, 81-95 (2011
26. Bogaert P., Tournoy K.G., Naessens T., & Grooten J. Where asthma and hypersensitivity pneumonitis meet and differ: noneosinophilic severe asthma. Am. J. Pathol. 174, 3-13 (2009
27. Thomas P.S., Yates D.H., & Barnes P.J. Tumor-necrosis-factor-alpha increases airway responsiveness and sputum neutrophilia in normal human-subjects. Am. J. Respir. Crit. Care Med. 152, 76-80 (1995
28. Wershil B.K., Wang Z.S., Gordon J.R., & Galli S.J. Recruitment of neutrophils during ige-dependent cutaneous late phase reactions in the mouse is mast cell-dependent -partial inhibition of the reaction with antiserum against tumor-necrosis-factor-alpha. J. Clin. Investig. 87, 446-453 (1991
29. Ito K., et al. Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma. Am. J. Respir. Cell Mol. Biol. 39, 543-550 (2008
30. Manni M.L., et al. The complex relationship between inflammation and lung function in severe asthma. Mucosal immunology 7, 1186-1198 (2007
31. Choi K.J., Zhang S.N., Choi I.K., Kim J.S., & Yun C.O. Strengthening of antitumor immune memory and prevention of thymic atrophy mediated by adenovirus expressing IL-12 and GM-CSF. Gene Therapy 19, 711-723 (2012
32. Rudmann D.G., et al. Modulation of allergic inflammation in mice deficient in TNF receptors. Am. J. Physiol. Lung Cell. Mol. Physiol. 279, L1047-L1057 (2000
33. Cho J.Y., Pham A., Rosenthal P., Miller M., Doherty T., & Broide D.H. ChronicOVA allergen challenged TNF p55/p75 receptor deficient mice have reduced airway remodeling. Int. Immunopharmacol. 11, 1038-1044 (2011
34. Agache I., Ciobanu C., Agache C., & Anghel M. Increased serum IL-17 is an independent risk factor for severe asthma. Respir. Med. 104, 1131-1137 (2010
35. Nakae S., Suto H., Berry G.J., & Galli S.J. Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbuminchallenged OTII mice. Blood 109, 3640-3648 (2007
36. McKinley L., et al. T(H)17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 181, 4089-4097 (2008
37. Fahy J.V., Kim K.W., Liu J., & Boushey H.A. Prominent neutrophilic inflammation in sputumfrom subjects with asthma exacerbation. J. Allergy Clin. Immunol. 95, 843-852 (1995
38. Saha S., et al. Granulocyte-macrophage colony-stimulating factor expression in induced sputum and bronchial mucosa in asthma and COPD. Thorax 64, 671-676 (2009
39. Hardyman M.A., et al. TNF-alpha-mediated bronchial barrier disruption and regulation by src-family kinase activation. J. Allergy Clin. Immunol. 132, 665-675 (2013
40. Cundall M., Sun Y.C., Miranda C., Trudeau J.B., Barnes S., & Wenzel S.E. Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucortcoids. J. Allergy Clin. Immunol. 112, 1064-1071 (2003
41. Tliba O., et al. Cytokines induce an early steroid resistance in airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 38, 463-472 (2008
42. Rider C.F., King E.M., Holden N.S., Giembycz M.A., & Newton R. Inflammatory stimuli inhibit glucocorticoid-dependent transactivation in human pulmonary epithelial cells: rescue by long-acting beta(2)-adrenoceptor agonists. J. Pharmacol. Exp. Ther. 338, 860-869 (2011
43. Marketon J.I.W., & Corry J. Poly I: C and respiratory syncytial virus (RSV) inhibit glucocorticoid receptor (GR)-mediated transactivation in lung epithelial, but not monocytic; cell lines. Virus Res. 176, 303-306 (2013
44. Ngo D., et al. Glucocorticoid-induced leucine zipper (GILZ) regulates testicular FOXO1 activity and spermatogonial stem cell (SSC) function. PLoS One, 8 (2013
45. Ying S., et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of TH2-attracting chemokines and disease severity. J. Immunol. 174, 8183-8190 (2005
46. Wang W.L., et al. Thymic stromal lymphopoietin: a promising therapeutic target for allergic diseases. Int Arch. Allergy Immunol. 160, 18-26 (2013
47. Zhang F., Huang G., Hu B., Song Y., & Shi Y. A soluble thymic stromal lymphopoietin (TSLP) antagonist, TSLPR-immunoglobulin, reduces the severity of allergic disease by regulating pulmonary dendritic cells. Clin. Exp. Immunol. 164, 256-264 (2011
48. Togbe D., et al. Thymic stromal lymphopoietin enhances Th2/Th22 and reduces IL-17A in protease-allergen-induced airways inflammation. ISRN Allergy 2013, 971036 (2013
49. Willart M.A., et al. Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J. Exp. Med. 209, 1505-1517 (2012
50. Peters M.C., Mekonnen Z.K., Yuan S., Bhakta N.R., Woodruff P.G., & Fahy J.V. Measures of gene expression in sputum cells can identify TH2-high and TH2-low subtypes of asthma. J. Allergy Clin. Immunol. 133, e5 (2014
51. Li D.Q., et al. Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways. J. Allergy Clin. Immunol. 128, e2 (2011
52. Chen L., Chen X., Zhang H., Feng L., & Zhu R. Carcinoma of the thyroid gland showing thymic-like elements: hypofunctioning nodule accumulating (99m)Tc-MIBI and (18)F-FDG. Hellenic J. Nuclear Med. 14, 190-191 (2011
53. Yilmaz O., et al. Comparison of TNF antagonism by etanercept and dexamethasone on airway epithelium and remodeling in an experimental model of asthma. Int. Immunopharmacol. 17, 768-773 (2013
54. Naumann L., Huscher D., Detert J., Spengler M., Burmester G.R., & Buttgereit F. Anti-tumour necrosis factor alpha therapy in patients with rheumatoid arthritis results in a significant and long-lasting decrease of concomitant glucocorticoid treatment. Ann. Rheum. Dis. 68, 1934-1936 (2009
55. Genovese T., et al. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma. Neuroscience 150, 168-181 (2007
56. Barnes P.J., & Adcock I.M. Glucocorticoid resistance in inflammatory diseases. Lancet 373, 1905-1917 (2009
57. Rothe J., et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798-802 (1993
58. Tanaka H., et al. The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflamm. Res. 50, 616-624 (2001
59. Hammad H., et al. Activation of the D prostanoid 1 receptor suppresses asthma by modulation of lung dendritic cell function and induction of regulatory T cells. J. Exp. Med. 204, 357-367 (2007